SIRION Biotech developed out of University of Munich (LMU), one of Germany's Elite Schools. Founders were scientists from the School's Gene Center conducting research on viral vectors, specifically adenovirus. The group is now being located in one Germany's R&D hotspots right outside Munich next to one of the country's most prominent University Hospitals, Grosshadern.

SIRION Biotech started in 2007 serving researchers worldwide with novel and custom viral vectors first in research, later also in clinical grade. SIRION Biotech collaborates with leading scientists across the country, in Denmark and in Austria. In addition, the company has hands-on experience from more than 300 single projects for more than 100 repeat clients, both industry and academia.

Please contact us for specific information of interest to you.